Related Experiment Videos
Polymyositis and dermatomyositis associated with malignancy: a 30-year retrospective study
Nobuo Wakata1, Teruyuki Kurihara, Eizo Saito
1Fourth Department of Internal Medicine, Toho University, School of Medicine, Tokyo, Japan. waka@oha.toho-u.ac.jp
International Journal of Dermatology
|November 28, 2002
Summary
Early cancer detection is crucial for polymyositis and dermatomyositis patients. These inflammatory myopathies are linked to malignancy, with higher cancer risk in older males with dermatomyositis.
Area of Science:
- Rheumatology
- Oncology
- Paraneoplastic Syndromes
Background:
- Polymyositis and dermatomyositis are inflammatory myopathies associated with malignancy.
- The incidence, treatment, and prognostic factors of cancer in these conditions remain unclear.
Purpose of the Study:
- To investigate the association between polymyositis/dermatomyositis and cancer.
- To identify factors predicting cancer risk and prognosis in these patients.
Main Methods:
- A retrospective study of 64 polymyositis and 28 dermatomyositis patients treated between 1969-1999.
- Comparison of clinical findings between patients with and without associated cancer.
Main Results:
- Cancer risk is significantly higher in dermatomyositis and elevated in polymyositis.
- Older males with dermatomyositis have an increased cancer risk.
- Malignancy is typically diagnosed within 4 years of the myositis diagnosis, often within 1 year.
Conclusions:
- Early detection of malignancy is critical for patients diagnosed with polymyositis or dermatomyositis.
- Timely diagnosis and intervention may improve outcomes for these paraneoplastic syndromes.